219 related articles for article (PubMed ID: 32269766)
1.
Lee CH; Koohy H
F1000Res; 2020; 9():145. PubMed ID: 32269766
[No Abstract] [Full Text] [Related]
2. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
Ahmed SF; Quadeer AA; McKay MR
Viruses; 2020 Feb; 12(3):. PubMed ID: 32106567
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Folegatti PM; Ewer KJ; Aley PK; Angus B; Becker S; Belij-Rammerstorfer S; Bellamy D; Bibi S; Bittaye M; Clutterbuck EA; Dold C; Faust SN; Finn A; Flaxman AL; Hallis B; Heath P; Jenkin D; Lazarus R; Makinson R; Minassian AM; Pollock KM; Ramasamy M; Robinson H; Snape M; Tarrant R; Voysey M; Green C; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
Lancet; 2020 Aug; 396(10249):467-478. PubMed ID: 32702298
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
5. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
[TBL] [Abstract][Full Text] [Related]
6. Epitopes for a 2019-nCoV vaccine.
Lucchese G
Cell Mol Immunol; 2020 May; 17(5):539-540. PubMed ID: 32094505
[No Abstract] [Full Text] [Related]
7. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.
Noorimotlagh Z; Karami C; Mirzaee SA; Kaffashian M; Mami S; Azizi M
Int Immunopharmacol; 2020 Sep; 86():106738. PubMed ID: 32683296
[TBL] [Abstract][Full Text] [Related]
8. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
[TBL] [Abstract][Full Text] [Related]
9. Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.
Poran A; Harjanto D; Malloy M; Arieta CM; Rothenberg DA; Lenkala D; van Buuren MM; Addona TA; Rooney MS; Srinivasan L; Gaynor RB
Genome Med; 2020 Aug; 12(1):70. PubMed ID: 32791978
[TBL] [Abstract][Full Text] [Related]
10. Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis.
Khairkhah N; Aghasadeghi MR; Namvar A; Bolhassani A
PLoS One; 2020; 15(10):e0240577. PubMed ID: 33057358
[TBL] [Abstract][Full Text] [Related]
11. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
van Doremalen N; Lambe T; Spencer A; Belij-Rammerstorfer S; Purushotham JN; Port JR; Avanzato VA; Bushmaker T; Flaxman A; Ulaszewska M; Feldmann F; Allen ER; Sharpe H; Schulz J; Holbrook M; Okumura A; Meade-White K; Pérez-Pérez L; Edwards NJ; Wright D; Bissett C; Gilbride C; Williamson BN; Rosenke R; Long D; Ishwarbhai A; Kailath R; Rose L; Morris S; Powers C; Lovaglio J; Hanley PW; Scott D; Saturday G; de Wit E; Gilbert SC; Munster VJ
Nature; 2020 Oct; 586(7830):578-582. PubMed ID: 32731258
[TBL] [Abstract][Full Text] [Related]
12. Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain:
Chukwudozie OS; Chukwuanukwu RC; Iroanya OO; Eze DM; Duru VC; Dele-Alimi TO; Kehinde BD; Bankole TT; Obi PC; Okinedo EU
J Immunol Res; 2020; 2020():2837670. PubMed ID: 32964056
[TBL] [Abstract][Full Text] [Related]
13. Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach.
Naz A; Shahid F; Butt TT; Awan FM; Ali A; Malik A
Front Immunol; 2020; 11():1663. PubMed ID: 32754160
[TBL] [Abstract][Full Text] [Related]
14. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.
Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M
Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699
[TBL] [Abstract][Full Text] [Related]
15. Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2.
Kalita P; Padhi AK; Zhang KYJ; Tripathi T
Microb Pathog; 2020 Aug; 145():104236. PubMed ID: 32376359
[TBL] [Abstract][Full Text] [Related]
16. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach.
Sanami S; Zandi M; Pourhossein B; Mobini GR; Safaei M; Abed A; Arvejeh PM; Chermahini FA; Alizadeh M
Int J Biol Macromol; 2020 Dec; 164():871-883. PubMed ID: 32682041
[TBL] [Abstract][Full Text] [Related]
17. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.
Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Lee SS; Chakraborty C
J Med Virol; 2020 Jun; 92(6):618-631. PubMed ID: 32108359
[TBL] [Abstract][Full Text] [Related]
18. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
[TBL] [Abstract][Full Text] [Related]
19. Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an
Kumar A; Kumar P; Saumya KU; Kapuganti SK; Bhardwaj T; Giri R
Expert Rev Vaccines; 2020 Sep; 19(9):887-898. PubMed ID: 32815406
[TBL] [Abstract][Full Text] [Related]
20. Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2-An in silico glance.
Marchan J
Hum Immunol; 2020; 81(10-11):588-595. PubMed ID: 32888767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
